Authors
Loading...
Randomized trial demonstrates PPP2R2C's role in radioresistance in nasopharyngeal carcinoma, suggesting novel therapeutic targets.
Fang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: